A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study

A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study

Abstract Background Selective internal radiation therapy (SIRT) with yttrium-90 (90Y) resin microspheres is an established locoregional treatment option for unresectable hepatocellular carcinoma (HCC), which delivers a lethal dose of radiation to hepatic tumors, while sparing surrounding healthy tis...

Full description

Bibliographic Details
Main Authors: Armeen Mahvash, Steven Chartier, Mark Turco, Paula Habib, Steven Griffith, Scott Brown, S. Cheenu Kappadath
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Gastroenterology
Subjects:
Radioembolization
SIRT
90Y resin microspheres
Hepatocellular carcinoma (HCC)
Online Access:https://doi.org/10.1186/s12876-022-02204-1

Internet

https://doi.org/10.1186/s12876-022-02204-1

Similar Items